EUCTR2004-002731-62-IT进行中（未招募）不适用
OPTIMISATION OF INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS BY TELECARE ASSISTANCE FOR SELF MONITORING OF BLOOD GLUCOSE ELEONOR STUDY
AVENTIS PHARMA S.P.A.0 个研究点目标入组 480 人开始时间: 2006年1月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 480
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Study on insulin treatment for type 2 diabetes performed by general practitionersType 2 diabetes mellitusJPRN-UMIN000011287General incorporated Tokyo Physicians Association.100
尚未招募
不适用
A Comparison of Peri-Operative and Post Acute Coronary Syndrome Glycaemic Control in Insulin Requiring Patients with Type 2 Diabetes at St Vincent’s Hospital With and Without Real-Time Continuous Glucose Monitoring.Type 2 diabetes requiring insulinAcute coronary syndromesPost - operative patientsMetabolic and Endocrine - DiabetesCardiovascular - Coronary heart diseaseSurgery - Surgical techniquesACTRN12608000125325St Vincent's Hospital60
已完成
3 期
Improved treatment of type 2 diabetes mellitus by improving the splenic functions and gastro intestinal tract using naturally occurring bioactive compoundsSplenic and gastro intestinal disorder in Type 2 Diabetes Mellitusgastrointestinal disorderMetabolic diseasesMetabolic and Endocrine - DiabetesDiabetes mellitusACTRN12614000007639guyen Van Toan94
已完成
不适用
Insulin combination therapy in type 2 diabetesDiabetes mellitus type 2 (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN29335793Stichting Julius Research (The Netherlands)200
进行中（未招募）
不适用
Treatment Strategies in Patients with Type 2 Diabetes Mellitus Not Achieving Glycemic Control while on Therapy with Premixed Insulin Analogues and Metformin: A Comparison of Insulin Lispro MM Intensive Mixture Therapy with Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70 - S019Type 2 Diabetes MellitusEUCTR2006-003076-35-HUEli Lilly and Company Ltd.270